Those who applied for < SomaGen(Reg.S)(950200) > achieved a 30% profit limit-up in just one day!
Congratulations to everyone who applied for the free trial. ^^
The leading domestic ‘this company’ announced a forecast that the patents of major global bio new drugs are expiring massively, creating a replacement market estimated to reach as much as 100 trillion KRW! Following semiconductors and automobiles, which were called export powerhouses, bio is expected to become an ‘export powerhouse’ as well! Since it already has a high market share and is preparing for clinical trials related to patents, it is expected to lead the market for over 10 years!
“It falls when I buy and rises when I sell” ? this happened more than once. It was so hard that I thought about quitting stocks many times. In desperation, I applied for the 3-day free trial, and my stock life changed 180 degrees here. I regretted not applying sooner because my account profit rate was so good. I am still very satisfied and using the VIP service.
(VIP full-time investor Kim Yong-su, 47 years old member)
Now think this is your last chance. If you miss this opportunity, you have to quit.
Exactly on “November 16” it will explode! Don’t miss it and regret it, buy at least 1 million KRW worth!
[AI recent limit-up hits]
*20.11.06 Solux(290690) limit-up hit!
*20.11.04 Senko(347000) limit-up hit!
*20.11.02 Syswork(269620) limit-up hit!
*20.10.30 Namseong(004270) limit-up hit!
*20.10.27 Phoenix Materials(050090) limit-up hit!
*20.10.23 ANP(015260) limit-up hit!
*20.10.21 Kyungin Electronics(009140) limit-up hit!
*20.10.19 KPX Life Science(114450) limit-up hit!
*20.10.16 Seohan(011370) limit-up hit!
*20.10.14 KMH Hightech(052900) limit-up hit!
*20.10.12 Access Bio(950130) limit-up hit!
*20.10.07 Camu E&C(013700) limit-up hit!
*20.10.05 Cellid(299660) limit-up hit!
▶▶ Only for 30 people. “Monday limit-up”! ▶ Get it now ◀
※ First-come, first-served 30 people closed! Both early and late rounds are over. The hero of the last injury time winning goal ※
[Today’s stocks of interest]
#ABProBio #Pharmicell #N2Tech #WooriBio #KPXLifeScience
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

